SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Investing Activities | ₹158 Cr | ₹392 Cr | ₹-548 Cr |
What is the latest Cash Flow from Investing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹158 Cr |
| Mar2024 | ₹392 Cr |
| Mar2023 | ₹-548 Cr |
How is Cash Flow from Investing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹158 Cr | -59.73 | |
| Mar2024 | ₹392 Cr | Positive | |
| Mar2023 | ₹-548 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,249.3 Cr | 9.7% | 32.4% | 23.3% | Stock Analytics | |
| SAGILITY | ₹18,950.0 Cr | 3.8% | -6% | 1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,512.3 Cr | 2.1% | -1.1% | -30.6% | Stock Analytics | |
| PRIME FOCUS | ₹18,456.9 Cr | -4.1% | -13.4% | 94.3% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,832.2 Cr | 0.3% | 11.9% | -12% | Stock Analytics | |
| INDEGENE | ₹12,314.9 Cr | -0.5% | -1.9% | -13% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 9.7% |
32.4% |
23.3% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses